ArticleTissue engineering. Part A2013

Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage.

Matteo Centola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.